Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 267, Issue 5, 2010, Pages 773-778

  He, Xia Yun ^a   Hu, Chao Su ^a   Ying, Hong Mei ^a   Wu, Yong Ru ^a   Zhu, Guo Pei ^a   Liu, Tai Fu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cisplatin; Concurrent chemoradiotherapy; Nasopharyngeal carcinoma; Paclitaxel

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CERVICAL LYMPH NODE; CHINESE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEARING LOSS; HEART ARRHYTHMIA; HUMAN; HYPERSENSITIVITY REACTION; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; THROMBOCYTOPENIA; VOMITING; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PACLITAXEL; RADIOTHERAPY DOSAGE; YOUNG ADULT;

EID: 77954539840     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-009-1112-7     Document Type: Article

References (31)

1. Yi JL, Gao L, Huang XD et al (2006) Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys 65:161-168
2. Gao JM, Zeng YX, Cui NJ et al (2005) Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy-checkout of Fuzhou staging system (1992). Ai Zheng 24:1165-1172
3. Lee AW, Sze WM, Au JS et al (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61:1107-1116
4. He XY, Liu TF, He SQ et al (2007) Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF). Radiother Oncol 85:29-35
5. Zhu XD, Wei JB, Qu S et al (2007) Comparison of remote results of conventional fractionation radiotherapy and late course accelerated hyperfractionation radiotherapy for nasopharyngeal carcinoma. Chin J Radiat Oncol 16:321-324
6. Kwong DL, Sham JS, Au GK et al (2004) Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 22:2643-2653
7. Chua DT, Sham JS, Au GK (2004) A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma. Head Neck 26:118-126
8. Jiang Y, Wei YQ, Luo F et al (2005) Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study. Cancer Invest 23:123-128
9. Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310-1317
10. Lee AW, Lau WH, Tung SY et al (2005) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23:6966-6975
11. Mostafa E, Nasar MN, Rabie NA et al (2006) Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma. J Egypt Natl Canc Inst 18:348-356
12. Citrin D, Mansueti J, Likhacheva A et al (2009) Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 74:1040-1046
13. Agarwala SS, Cano E, Heron DE et al (2007) Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer. Ann Oncol 18:1224-1229
14. Pignon JP, le Maitre A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69:S112-S114 (Pubitemid 47369400)
15. Disilvestro PA, Walker JL, Morrison A et al (2006) Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group. Gynecol Oncol 103:1038-1042
16. Kao J, Conzen SD, jaskowiak NT et al (2005) Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials. Int J Radiat Oncol Biol Phys 61:1045-1053
17. Hsu FM, Lin CC, Lee JM et al (2008) Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study. J Surg Oncol 98:34-41
18. Yap SP, Lim WT, Foo KF et al (2008) Induction concurrent chemoradiotherapy using Paclitaxel and Carboplatin combination followed by surgery in locoregionally advanced non-small cell lung cancer-Asian experience. Ann Acad Med Singapore 37:377-382
19. Langer CJ, Harris J, Horwitz EM et al (2007) Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 25:4800-4805
20. Fountzilas G, Tolis C, Kalogera-Fountzila A et al (2005) Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study. Med Oncol 22:269-279
21. Barone C, Grillo R, Dongiovanni D et al (2008) Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma. Anticancer Res 28:1285-1291
22. Hancock SB, Krempl GA, Canffeld V et al (2008) Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy. Laryngoscope 118:1357-1361
23. Hu QY, Liu P, Wang L et al (2007) Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III, IV a nasopharyngeal carcinoma. Ai zhen 26:394-397
24. Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582-3589
25. Rades D, Fehlauer F, Sheikh-Sarraf M et al (2008) Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer. Head Neck 30:235-241
26. Chan AT, Teo PML, Ngan RK et al (2002) Concurrent chemotherapy- radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III radiomized trial. J Clin Oncol 20:2038-2044
27. Demizu Y, Sasaki R, Soejima T et al (2006) Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma. Jpn J Clin Oncol 36:620-625
28. Vaupel P, Mayer A, Hockel M (2006) Impact Of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol 182:63-71
29. Chau RM, Teo PM, Kam MK et al (2007) Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim 32:263-270
30. Yeh SA, Tang Y, Lui CC et al (2005) Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62:672-679
31. Kong L, Zhang YW, Wu YR et al (2006) Late side reactions of longterm survivors after radiotherapy for nasopharyngeal carcinoma. Chin J Radiat Oncol 15:151-156